Methotrexate Sodium Injection — FDA Drug Shortage
The FDA lists a drug shortage record for Methotrexate Sodium Injection (injection) from Teva Pharmaceuticals USA, Inc. with status Current. The shortage was first posted on Mar 13, 2023. Reported reason: Other
Shortage details
- Status
- Current
- Company
- Teva Pharmaceuticals USA, Inc.
- Package NDC
- 0703-3675-01
- Dosage Form
- Injection
- Presentation
- Methotrexate Sodium Preservative Free, Injection, 25 mg/1 mL (NDC 0703-3675-01)
- Initial Posting
- Mar 13, 2023
Reason
Other